Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Foundation for Women's Cancer Alerts Women to the Link Between Obesity and Endometrial Cancer

      September 4, 2014
      News
      Article

      Endometrial cancer is the most common gynecologic cancer and the fourth most common cancer.

      The Foundation for Women’s Cancer will participate in Gynecologic Cancer Awareness Month in September by alerting women to the link between obesity and endometrial cancer, and urging them to know the symptoms of endometrial cancer.

      Endometrial cancer is the most common gynecologic cancer and the fourth most common cancer. More than 52,600 will learn of a diagnosis this year alone. It is especially important for women with weight management challenges to know the early warning signs of the cancer. They include: abnormal vaginal bleeding; younger women should note irregular bleeding; and any vaginal bleeding after menopause should be evaluated by a physician, preferably a gynecologist.

      Other risks for endometrial cancer include: taking estrogen alone without progesterone; diabetes; hypertension; menopause (after age 52); never becoming pregnant; and a family history of colon cancer or other type of uterine cancer.

      Every woman is at risk for developing a gynecologic cancer. An estimated 95,000 new cases will be diagnosed and approximately 29,000 women, or nearly a third, will die from gynecologic cancers in the US in 2014.

      The Foundation for Women’s Cancer first declared September as Gynecologic Cancer Awareness Month in 1999. Since then, the Foundation has been joined by organizations throughout the country to bring life-saving messages to women.

      During GCAM in September and throughout the year, the Foundation for Women’s Cancer will focus increased emphasis on helping women understand the steps they can take to reduce the risks for these cancers and receive the earliest possible diagnosis through symptom recognition.

      On Sunday, November 2, the Foundation’s major national awareness and fundraising event, the National Race to End Women’s Cancer 5K, takes place in Washington, DC. Register, donate, sponsor or learn more here.

      The Foundation for Women’s Cancer is dedicated to raising funds for research and training, and increasing public awareness of gynecologic cancer prevention, early detection and optimal treatment. Visit foundationforwomenscancer.org.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Johanna Garibaldi
      Gynecologic Cancers
      Related Content

      Photo of a person holding their abdomen in discomfort

      Olanzapine May Reduce Nausea, Vomiting From Radiation

      Roman Fabbricatore
      June 9th 2025
      Article

      Olanzapine plus an antiemetic shows potential in preventing RINV while reducing other adverse events such as depression, appetite loss, and insomnia.


      The Vitals

      Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

      Lindsay Fischer
      November 15th 2023
      Podcast

      Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.


      Graphic depicting the female reproductive system with cancer cells surrounding

      Adavosertib Yields Preliminary Safety Concerns, Antitumor Activity in USC

      Ashley Chan
      May 12th 2025
      Article

      Treatment-related adverse effects were reported in 97.2% of heavily pretreated patients with uterine serous carcinoma taking adavosertib.


      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      October 2nd 2023
      Podcast

      Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.


      Image of patients of different ages in a waiting room

      Risk Factors Determine Symptom Burden Profiles by Age Group

      Bridget Hoyt
      April 18th 2025
      Article

      Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with cancer.


      Photo of a nurse holding a clipboard and talking to a patient

      Patient-Centered Communication Drives Supportive Care Needs in Incurable Cancer

      Kristie L. Kahl
      April 16th 2025
      Article

      The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable gynecologic cancer treatment.

      Related Content

      Photo of a person holding their abdomen in discomfort

      Olanzapine May Reduce Nausea, Vomiting From Radiation

      Roman Fabbricatore
      June 9th 2025
      Article

      Olanzapine plus an antiemetic shows potential in preventing RINV while reducing other adverse events such as depression, appetite loss, and insomnia.


      The Vitals

      Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

      Lindsay Fischer
      November 15th 2023
      Podcast

      Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.


      Graphic depicting the female reproductive system with cancer cells surrounding

      Adavosertib Yields Preliminary Safety Concerns, Antitumor Activity in USC

      Ashley Chan
      May 12th 2025
      Article

      Treatment-related adverse effects were reported in 97.2% of heavily pretreated patients with uterine serous carcinoma taking adavosertib.


      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      October 2nd 2023
      Podcast

      Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.


      Image of patients of different ages in a waiting room

      Risk Factors Determine Symptom Burden Profiles by Age Group

      Bridget Hoyt
      April 18th 2025
      Article

      Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with cancer.


      Photo of a nurse holding a clipboard and talking to a patient

      Patient-Centered Communication Drives Supportive Care Needs in Incurable Cancer

      Kristie L. Kahl
      April 16th 2025
      Article

      The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable gynecologic cancer treatment.

      Latest Conference Coverage

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer Mutations

      AI Tool May Predict Response, Resistance in Advanced RCC

      Olanzapine May Reduce Nausea, Vomiting From Radiation

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.